1Eicosanoid, prostaglandin, thromboxane and leukotriene acts on an or . They do not travel to regulate elsewhere.
Eicosanoid, prostaglandin, thromboxane and leukotriene acts on an adjacent cell or themselves. They do not travel to regulate elsewhere.
2All of the eicosanoids are or signaling molcules. They are synthesized in tissues.
All of the eicosanoids are autocrine or paracrine signaling molcules. They are synthesized in all tissues.
3All of the eicosanoids are derived from
All of the eicosanoids are derived from arachidonic acid
4Arachidonic acid is a C-20 compount with double bonds between
Arachidonic acid is a C-20 compount with double bonds between 5, 8, 11, 14
5Arachindonic acid becomes using the enzyme
Arachindonic acid becomes 5-hydroperoxyeicostatetraenoic acid (5-HPETE) using the 5-lipoxygenase enzyme
6The 5 lipoxygenase enzyme is inhibited by
The 5 lipoxygenase enzyme is inhibited by Zyflo (Zileuton)
7 causes the release of membranse bound arachidonic acid
Phospholipase A2 causes the release of membranse bound arachidonic acid

8Phospholipase A2 is inhibited by
Phospholipase A2 is inhibited by
cortisol 
9Arachidonic acid is converted to PG and TX by
Arachidonic acid is converted to PG and TX by COX
10Archidonic acid is converted to LT by
Archidonic acid is converted to LT by lipoxygenase
11COX-1 is found in
COX-1 is found in most tissues
12COX-1 is needed for healthy , ,
COX-1 is needed for healthy gastric tissue, renal homeostasis, platelet aggregation
13COX-2 is found in and
COX-2 is found in immune and inflammatory cells
14COX-2 Mediates , , , , , and
COX-2 Mediates pain, heat, redness, swelling, inflammation, and fever
15NSAID are inhibited by by blocking the production of parent
NSAID are inhibited by COX1 and COX2 by blocking the production of parent PGH2
16Cortisol inhibits ONLY by blocking
Cortisol inhibits ONLY CoX-2 by blocking phospholipase A2
17Prostacyclin (PGI2) are produced by that inhibit
and
stimulates and
blocks .
Prostacyclin (PGI2) are produced by vascular
endothelial cells that inhibit
platelet aggregation and
stimulates vasodilation and
blocks thrombogenesis.
18PGF2a is made by and is produced by the
PGF2a is made by most tissues and is produced by the corpus luteum.
19PGF2a does Contraction of and stimulates
PGF2a does Contraction of Smooth Muscle and stimulates Uterine
Contraction
20Thromboxanes
A2 (TXA2) is
produced in .
TXA2 promotes adherence and
aggregation of and and
(thrombi)
formation.
Thromboxanes
A2 (TXA2) is
produced in activated platelets.
TXA2 promotes adherence and
aggregation of circulating
platelets and contraction of
vascular smooth muscle and
promotes clot (thrombi)
formation.
21While blocks platelet aggregation, promotes it
While PGI2 (prostacyclin) blocks platelet aggregation, TXA2 (thromboxane) promotes it
22LTA4 is derived from
LTA4 is derived from 5-HPETE
23LTA4 produced in . It is found in , , and
LTA4 produced in Leucocytes. It is found in Mast Cells, Platelets, heart and
lung
24LTB4 (Leucotriene B4) in increased . It functions to and .
LTB4 (Leucotriene B4) in polymorphonuclear
leucocytes increased chemotaxis. It functions to release lysosomal enzymes and adhere white blood cells.
25LTE4 (Leucotriene E4) is involved in ,
, Increased , and .
LTE4 (Leucotriene E4) is involved in Bronchoconstriction,
Vasoconstriction, Increased Vascular Permeability, and contraction of Smooth Muscle.
26LTE4 (Leucotriene E4) is a Slow Reacting Substances of
LTE4 (Leucotriene E4) is a Slow Reacting Substances of Anaphylaxis (SRS‐A)
27LTE4 (Leucotriene E4) inhibitors include and
LTE4 (Leucotriene E4) inhibitors include Accolate (Zafirlukast) and
Montelucast
28Draw out the general schematic for asprin
Draw out the general schematic for asprin

29 is used in which is used for treatment of asthma, excersise induced bronchospasm, and allergic rhinitis
Montelucast is used in sigulair which is used for treatment of asthma, excersise induced bronchospasm, and allergic rhinitis
30Sphingolipid synthesis is initiated between and by . Results in the production of .
Sphingolipid synthesis is initiated between
Palmitoyl CoA and
L-serine by
serine palmitoyl transferase (SPT) . Results in the production of
sphingomyelin.

31Sphingolipid synthesis is initiated between and by . Results in the production of .
Sphingolipid synthesis is initiated between
Palmitoyl CoA and
L-serine by
serine palmitoyl transferase (SPT) . Results in the production of
sphingomyelin.

32What are the two compounds needed to synthesize sphingolipids?
Palmitoyl-CoA and L-Serine
33What inhibits serine palmitoyl transferase?
Myriocin

34What inhibits ceramide synthase?
Fumonisin B1

35 is a genetic skin disorder that affects males. It is an inborn error of metabolism characterized by a of the enzyme
X-linked ichthyosis is a genetic skin disorder that affects males. It is an inborn error of metabolism characterized by a deficiency of the enzyme steroid sulfatase